Barely Significant
← all excerpts

GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy.

Front Endocrinol (Lausanne) · 2024 · PMC11091257 · PMID 38745956

1
hedged sentence
closest p
boldest claim

The sentences

When comparing metabolic parameters pre and post the 2-week treatment, we observed that liraglutide significantly lowered fat mass in male WT mice, however similar changes failed to reach statistical significance in female WT mice ( Figure 2E ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.